Showing results (2241-2250 of 2,339) with videos related to
Sort By:
Pageof 234
Alcohol (Fayetteville, N.Y.)|June 16, 2015
Brain pathways to recovery from alcohol dependenceChanghai Cui, Antonio Noronha, Kenneth R Warren, et al.Carcinogenesis|August 31, 2018
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal diseaseThomas U Ahearn, Sam Peisch, Andreas Pettersson, et al.Environmental Health Perspectives|February 6, 2024
Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health DashboardAvanti V Shirke, Elizabeth G Radke, Cynthia Lin, et al.Fungal Genetics and Biology : FG & B|June 1, 1997
Expressed sequences from conidial, mycelial, and sexual stages of Neurospora crassaM A Nelson, S Kang, E L Braun, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2014
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care settingLuis Ostrosky-Zeichner, Shmuel Shoham, Jose Vazquez, et al.Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.JAMA Surgery|April 3, 2020
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant ImatinibAlessandro Gronchi, Sylvie Bonvalot, Andres Poveda Velasco, et al.Scientific Reports|July 12, 2014
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathwayRuili Huang, Srilatha Sakamuru, Matt T Martin, et al.Molecular Cancer Therapeutics|October 22, 2017
ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK IsoformsKasey L Couts, Judson Bemis, Jacqueline A Turner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasPaolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.Pageof 234